Perseghin G, Caloni M, Mazzaferro V, Luzi L
Recenti Prog Med. 2001 Dec;92(12):757-61.
Peripheral insulin-resistance and impairment of the hepatocellular function are two major possible causes of diabetes mellitus in liver cirrhosis. The pathogenesis of insulin-resistance (receptorial or post-receptorial) is unknown but it represents an important complication because it has a profound impact on the pathology and natural history of the liver disease. The beta-cell capacity, to compensate the insulin-resistant state to avoid the onset of frank diabetes mellitus plays a critical importance. Many factors may induce a reduction of the beta-cell function in patients with liver cirrhosis: some are due to a predisposition to the development of diabetes: genetic or environmental, unrelated to the hepatic disease; some others are hepatic disease-dependent (excess liver and islet of Langerhans iron deposition, HCV infection rather than other hepatic infections, the co-presence of HCC) and may be crucial because additive to the previous. It is likely that the high prevalence of diabetes in liver cirrhosis is due to the early onset of strong insulin-resistance coupled to a deficient beta-cell function aggravated by hepatic disease-related factors.
外周胰岛素抵抗和肝细胞功能损害是肝硬化患者发生糖尿病的两个主要可能原因。胰岛素抵抗(受体或受体后)的发病机制尚不清楚,但它是一种重要的并发症,因为它对肝脏疾病的病理和自然史有深远影响。β细胞补偿胰岛素抵抗状态以避免发生明显糖尿病的能力起着至关重要的作用。许多因素可能导致肝硬化患者β细胞功能降低:一些是由于患糖尿病的易感性:遗传或环境因素,与肝脏疾病无关;其他一些则取决于肝脏疾病(肝脏和胰岛铁沉积过多、丙型肝炎病毒感染而非其他肝脏感染、合并肝细胞癌),可能至关重要,因为它们与前者相加。肝硬化患者糖尿病的高患病率可能是由于强烈的胰岛素抵抗早期出现,再加上肝脏疾病相关因素加重了β细胞功能缺陷。